MediPal : Notice Regarding Dividends of Retained Earnings (Dividend Increase)

About this update from Medipal Holdings Corporation

May 14, 2026 MEDIPAL HOLDINGS CORPORATION Representative: Shuichi Watanabe, Representative Director, President and CEO Code number: 7459 (Prime Market, Tokyo Stock Exchange) Contact: Toshiyuki Ikeuchi, Executive Officer, Head of Corporate Communications Department, Corporate Planning Division Tel: +81-3-3517-5171 Notice Regarding Dividends of Retained Earnings (Dividend Increase) At a meeting of the Board of Directors held on May 14, 2026, MEDIPAL HOLDINGS CORPORATION ("MEDIPAL") resolved to pay a dividend of retained earnings with a record date of March 31, 2026. The details are as follows. Details of year-end dividend Determined amount Previous forecast (Announced on May 13, 2025) Actual results for the fiscal year (Fiscal year ended March 31, 2025) Record date March 31, 2026 March 31, 2026 March 31, 2025 Dividend per share ¥34.00 ¥32.00 ¥32.00 Total amount of dividends ¥6,959 million - ¥6,654 million Effective date June 2, 2026 - June 3, 2025 Source of dividends Retained earnings - Retained earnings Reason MEDIPAL considers returns to shareholders one of its highest management priorities. MEDIPAL is pursuing the optimal capital structure while ensuring financial soundness, and, as a general principle, will maintain or increase its dividend payout ratio on earnings before amortization of goodwill and intangible assets arising from the growth investments set forth in the "2027 MEDIPAL Medium-Term Vision ―Change the Oroshi F orever―Constant Innovation". Simultaneously, MEDIPAL will comprehensively assess demand for funding and flexibly implement share buybacks and cancellations of shares as appropriate for the purpose of improving capital efficiency and further returning profits to shareholders. In consideration of the aforementioned policy and the financial condition for the fiscal year as well as other factors, MEDIPAL has decided to revise the year-end dividend for the fiscal year ended March 31, 2026 to ¥34.00 per share, an increase of ¥2.00 from the previous forecast. As a result, total dividends for the fiscal year is ¥66.00 per share, including the interim dividend (end of 2nd quarter) of ¥32.00 that was already paid. ＜Reference ＞ Breakdown of annual dividends Dividends per Share (Yen) End of 2nd quarter Year-End Total Fiscal year ended March 31, 2026 32.00 34.00 66.00 Fiscal year ended March 31, 2025 30.00 32.00 62.00 # # # The English version of this document is a translation of the Japanese original and is provided for information purposes only. While reasonable efforts have been made to provide an accurate translation, no liability is assumed by MEDIPAL HOLDINGS CORPORATION for any errors, omissions, or ambiguities in the translation. In the event of any inconsistency or conflict between the English version and the Japanese original, the Japanese original shall prevail.

View stock analysis, news, and events for Medipal Holdings Corporation